1. Home
  2. EVH vs MDXG Comparison

EVH vs MDXG Comparison

Compare EVH & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolent Health Inc

EVH

Evolent Health Inc

HOLD

Current Price

$4.18

Market Cap

469.0M

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$3.74

Market Cap

530.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVH
MDXG
Founded
2011
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.0M
530.2M
IPO Year
2015
2007

Fundamental Metrics

Financial Performance
Metric
EVH
MDXG
Price
$4.18
$3.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
6
Target Price
$7.93
$9.00
AVG Volume (30 Days)
2.7M
1.3M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
$907,957,000.00
$418,630,000.00
Revenue This Year
$33.89
N/A
Revenue Next Year
$15.84
$13.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.99
52 Week Low
$2.10
$3.03
52 Week High
$11.92
$7.99

Technical Indicators

Market Signals
Indicator
EVH
MDXG
Relative Strength Index (RSI) 57.07 54.46
Support Level $3.67 $3.45
Resistance Level $4.20 $3.80
Average True Range (ATR) 0.28 0.13
MACD -0.01 0.02
Stochastic Oscillator 61.69 63.75

Price Performance

Historical Comparison
EVH
MDXG

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: